Dogwood Therapeutics sets fall timeline for Halneuron Phase 2b data on chemotherapy-related neuropathic pain.
Observed price moves
- DWTX+3.04%15 min after this headline
MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next. We pay about $120,000 a month for the newswires behind this feed.